Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds
Meeting ReportGeneral Clinical Specialties

Assessing global coronary artery disease with NaF-PET/CT: Introducing the Alavi-Carlsen Calcification Score (ACCS)

Sze Jia Ng, Hui Chong Lau, William Raynor, Thomas Werner, Mona-Elisabeth Revheim, Babak Saboury and Abass Alavi
Journal of Nuclear Medicine June 2022, 63 (supplement 2) 2681;
Sze Jia Ng
1Crozer-Chester Medical Center
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hui Chong Lau
1Crozer-Chester Medical Center
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
William Raynor
2University of Pennsylvania
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thomas Werner
3Hospital of the University of Pennsylvania
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mona-Elisabeth Revheim
4Oslo University Hospital and University of Oslo
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Babak Saboury
5National Institutes of Health (NIH) - Clinical Center
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Abass Alavi
2University of Pennsylvania
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

2681

Introduction: 1. Review the conventional methods in evaluating coronary artery disease (CAD) and discuss the utilization of molecular imaging in CAD. 2. Discuss the advantages of 18F-sodium fluoride (NaF) as a PET tracer in atherosclerosis imaging. 3. Introduce the Alavi-Carlsen Calcification Score (ACCS) as a method of global assessment of micro-calcification in CAD.

Methods: CAD is the leading cause of morbidity and mortality worldwide, and atherosclerosis is the known major contributing disease process. Atherosclerosis is a complex and progressive process which can begin as early as in childhood with the development of fatty streaks, followed by molecular micro-calcification of atheromatous plaques, and gradually progressing to structural macro-calcification under the influence of the inflammatory mechanism, leading to the risk of plaque rupture and eventually vessel occlusion. Additionally, coronary artery calcification has been proven as an important independent predictor of CAD events. Therefore, it is of utmost importance to develop diagnostic methods that can identify micro-calcification of the vessels in the early stages. Over the past few decades, the evolution of imaging techniques has improved the evaluation of CAD. The most established non-invasive diagnostic imaging for identifying atherosclerosis is computed tomography (CT) using the coronary artery calcium score (CACS), a reliable metric for macro-calcification burden. Similarly, other conventional imaging modalities such as coronary computed tomographic angiography (CTA) and cardiac magnetic resonance imaging (MRI) have proven beneficial in detecting macro-calcification but are of limited ability to visualize micro-calcification in early stages of atherosclerosis. Invasive coronary angiography, which has been the gold standard for coronary atherosclerosis imaging, does not exhibit the ability for direct imaging of micro-calcification. In contrast, positron emission tomography (PET) molecular imaging is able to detect early-stage CAD with 18F-fluorodeoxyglucose (FDG) and NaF, markers of inflammation and micro-calcification, respectively.

Results: Previous studies of NaF have shown that its uptake is significantly correlated with the risk factors of CAD and the incidence of myocardial infarction. It has been demonstrated that coronary NaF uptake precedes macroscopic calcification and that there is no accumulation of NaF in the myocardium. The Alavi–Carlsen Calcification Score (ACCS) was introduced based on the concept of global disease assessment as applied to atherosclerosis imaging rather than focusing on individual plaques. The score is derived from measuring the total NaF uptake by segmenting the entire heart from the surrounding tissues and calculating the average standardized uptake value (SUVmean). Since the score is measured based on clearly delineated anatomical boundaries, it has less inter-rater variation. Furthermore, the implementation of artificial intelligence (AI)-based approaches in ACCS would ensure a fast and reliable method.

Conclusions: Global assessment of CAD using ACCS has the potential to detect and quantify burden of disease by reliably detecting molecular changes not apparent by other means. This represents a landmark approach, with implications for both the diagnosis and treatment of CAD.

Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 63, Issue supplement 2
June 1, 2022
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Assessing global coronary artery disease with NaF-PET/CT: Introducing the Alavi-Carlsen Calcification Score (ACCS)
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Assessing global coronary artery disease with NaF-PET/CT: Introducing the Alavi-Carlsen Calcification Score (ACCS)
Sze Jia Ng, Hui Chong Lau, William Raynor, Thomas Werner, Mona-Elisabeth Revheim, Babak Saboury, Abass Alavi
Journal of Nuclear Medicine Jun 2022, 63 (supplement 2) 2681;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Assessing global coronary artery disease with NaF-PET/CT: Introducing the Alavi-Carlsen Calcification Score (ACCS)
Sze Jia Ng, Hui Chong Lau, William Raynor, Thomas Werner, Mona-Elisabeth Revheim, Babak Saboury, Abass Alavi
Journal of Nuclear Medicine Jun 2022, 63 (supplement 2) 2681;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Embryology, anatomy, physiology, and normal and abnormal radiopharmaceutical concentration in the pituitary gland: An educational exhibit
  • Is Imaging of Bacteria with PET a realistic goal?
  • Multimodality imaging in calcific uremic arteriolopathy
Show more General Clinical Specialties

Similar Articles

SNMMI

© 2023 Journal of Nuclear Medicine

Powered by HighWire